Short-term reaction of choroidal neovascularization and choriocapillaris to photodynamic therapy in age-related macular degeneration

European Journal of Ophthalmology

Volumn 13, Issue 8, 2003, Pages 687-692

  Eter, Nicole ^a   Vogel, A ^a   Inhetvin Hutter, C ^a   Spitznas, M ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Control intervals; Photodynamic therapy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ARTICLE; CHOROID CAPILLARY LAYER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REPERFUSION; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0242596330     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210301300804     Document Type: Article

References (10)

1. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP report 1. Arch Ophthalmol 1999; 117: 1329-45.
2. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 2001; 119: 198-20.
3. Miller W, Schmidt-Erfurth U, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration. Arch Ophthalmol 1999; 117: 1161-73.
4. Schmidt-Erfurth U, Hasan T. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 2000; 45: 195-213.
5. Husain D, Kramer M, Kenny AG, et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci 1999; 40: 2322-31.
6. Miller JW, Walsh AW, Kramer, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein delivered benzoporphyrin. Arch Ophthalmol 1995; 113: 810-8.
7. Michels S, Barbazetto I, Schmidt-Erfurth U. Aderhautverän derungen nach photodynamischer Therapie (PDT) Verlaufsbeobachtungen über 2 Jahre bei 38 Patienten. Klin Monatsbl Augenheilkd 2000; 217: 94-9.
8. Schmidt-Erfurth U, Michels S, Barbazeto I, Laqua H. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci 2002; 43: 830-41.
9. Hager A, Schmidt-Erfurth U, Barbazetto I, et al. Photodynamische Therapie: ICG-angiographische Befunde. Ophthalmologe 1999; 96: 291-9.
10. Stur M, VER Study Group. Rationale for and design of the Visudyne in Early Retreatment (VER) trial. Invest Ophthalmol Vis Sci 2001; 42 (Suppl): S442-5.